Skip to main content
Erschienen in: Cancer Causes & Control 4/2006

01.05.2006 | Special Section on Cancer and Rhythm

Tumor Suppression by the Mammalian Period Genes

verfasst von: Cheng Chi Lee

Erschienen in: Cancer Causes & Control | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

The Period (Per) genes are key circadian rhythm regulators in mammals. Expression of the mouse Per (mPer) genes have diurnal pattern in the suprachiamstic nuclei and in peripheral tissues. Genetic ablation mPER1 and mPER2 function results in a complete loss of circadian rhythm control based on wheel running activity in mice. In addition, these animals also display apparent premature aging and significant increase in neoplastic and hyperplastic phenotypes. When challenged by γ-radiation, mPer2 deficient mice response by rapid hair graying, are deficient in p53-mediated apoptosis in thymocytes and have robust tumor occurrences. Our studies have demonstrated that the circadian clock function is very important for cell cycle, DNA damage response and tumor suppression in vivo. Temporal expression of genes involved in cell cycle regulation and tumor suppression, such as c-Myc, Cyclin D1, Cyclin A, Mdm-2 and Gadd45α is deregulated in mPer2 mutant mice. In addition, genetic studies have demonstrated that many key regulators of cell cycle and growth control are also important circadian clock regulators confirming the critical role of circadian function in organismal homeostasis. Recently studies of human breast and endometrial cancers revealed that the loss and deregulation of PERIOD proteins is common in the tumor cells.
Literatur
1.
Zurück zum Zitat Sun ZS, Albrecht U, Zhuchenko O, Bailey J, Eichele G, Lee CC (1997) RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell 90:1003–1011CrossRefPubMed Sun ZS, Albrecht U, Zhuchenko O, Bailey J, Eichele G, Lee CC (1997) RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell 90:1003–1011CrossRefPubMed
2.
Zurück zum Zitat Albrecht U, Sun ZS, Eichele G, Lee CC (1997) A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 91:1055–1064CrossRefPubMed Albrecht U, Sun ZS, Eichele G, Lee CC (1997) A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 91:1055–1064CrossRefPubMed
3.
Zurück zum Zitat Zylka MJ, Shearman LP, Weaver DR, Reppert SM (1998) Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 20:1103–1110CrossRefPubMed Zylka MJ, Shearman LP, Weaver DR, Reppert SM (1998) Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 20:1103–1110CrossRefPubMed
4.
Zurück zum Zitat Zheng B, Larkin DW, Albrecht U, etal. (1999) The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400:169–173CrossRefPubMed Zheng B, Larkin DW, Albrecht U, etal. (1999) The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400:169–173CrossRefPubMed
5.
Zurück zum Zitat Balsalobre A, Damiola F, Schibler U (1998) A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93:929–937CrossRefPubMed Balsalobre A, Damiola F, Schibler U (1998) A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93:929–937CrossRefPubMed
6.
Zurück zum Zitat Zheng B, Albrecht U, Kaasik K, etal. (2001) Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105:683–694CrossRefPubMed Zheng B, Albrecht U, Kaasik K, etal. (2001) Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 105:683–694CrossRefPubMed
7.
Zurück zum Zitat Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu YH (2001) An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291:1040–1043CrossRefPubMed Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu YH (2001) An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291:1040–1043CrossRefPubMed
8.
Zurück zum Zitat Lee C, Weaver DR, Reppert SM (2004) Direct association between mouse PERIOD and CKIepsilon is critical for a functioning circadian clock. Mol Cell Biol 24:584–594PubMed Lee C, Weaver DR, Reppert SM (2004) Direct association between mouse PERIOD and CKIepsilon is critical for a functioning circadian clock. Mol Cell Biol 24:584–594PubMed
9.
Zurück zum Zitat Shiromani PJ, Xu M, Winston EM, Shiromani SN, Gerashchenko D, Weaver DR (2004) Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 287:47–57 Shiromani PJ, Xu M, Winston EM, Shiromani SN, Gerashchenko D, Weaver DR (2004) Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol 287:47–57
10.
Zurück zum Zitat Fu L, Pelicano H, Liu J, Huang P, Lee CC (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41–50PubMed Fu L, Pelicano H, Liu J, Huang P, Lee CC (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41–50PubMed
11.
Zurück zum Zitat Barlow C, Eckhaus MA, Schaffer AA, Wynshaw-Boris A (1999) Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat Genet 21:359–360PubMed Barlow C, Eckhaus MA, Schaffer AA, Wynshaw-Boris A (1999) Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat Genet 21:359–360PubMed
12.
Zurück zum Zitat Kawara S, Mydlarski R, Mamelak AJ, etal. (2002) Low-dose ultraviolet B rays alter the mRNA expression of the circadian clock genes in cultured human keratinocytes.J Invest Dermatol 119:1220–1223CrossRefPubMed Kawara S, Mydlarski R, Mamelak AJ, etal. (2002) Low-dose ultraviolet B rays alter the mRNA expression of the circadian clock genes in cultured human keratinocytes.J Invest Dermatol 119:1220–1223CrossRefPubMed
13.
Zurück zum Zitat Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348CrossRefPubMed Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348CrossRefPubMed
14.
Zurück zum Zitat Jamerson MH, Johnson MD, Dickson RB (2004) Of mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 9:27–37CrossRefPubMed Jamerson MH, Johnson MD, Dickson RB (2004) Of mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 9:27–37CrossRefPubMed
15.
Zurück zum Zitat Tao H, Umek RM (1999) Reciprocal regulation of gadd45 by C/EBPalpha and c-Myc DNA. Cell Biol 18:75–84CrossRefPubMed Tao H, Umek RM (1999) Reciprocal regulation of gadd45 by C/EBPalpha and c-Myc DNA. Cell Biol 18:75–84CrossRefPubMed
16.
Zurück zum Zitat Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255–259CrossRefPubMed Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302:255–259CrossRefPubMed
17.
Zurück zum Zitat Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005 Mar 24; [Epub ahead of print] Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005 Mar 24; [Epub ahead of print]
18.
Zurück zum Zitat Yeh KT, Yang MY, Liu TC, etal. (2005) Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol 206:111–120CrossRefPubMed Yeh KT, Yang MY, Liu TC, etal. (2005) Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol 206:111–120CrossRefPubMed
19.
Zurück zum Zitat Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T (2005) Period3 structural variation:a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268–270PubMed Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T (2005) Period3 structural variation:a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268–270PubMed
20.
Zurück zum Zitat Stevens RG (2005) Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16:254–258PubMed Stevens RG (2005) Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16:254–258PubMed
21.
22.
Zurück zum Zitat Xu X, Landesman-Bollag E, Channavajhala PL, Seldin DC (1999) Murine protein kinase CK2: gene and oncogene. Mol Cell Biochem 191:65–74CrossRefPubMed Xu X, Landesman-Bollag E, Channavajhala PL, Seldin DC (1999) Murine protein kinase CK2: gene and oncogene. Mol Cell Biochem 191:65–74CrossRefPubMed
23.
Zurück zum Zitat Yang Y, Cheng P, Liu Y (2002) Regulation of the Neurospora circadian clock by casein kinase II. Genes Dev 16:994–1006CrossRefPubMed Yang Y, Cheng P, Liu Y (2002) Regulation of the Neurospora circadian clock by casein kinase II. Genes Dev 16:994–1006CrossRefPubMed
24.
Zurück zum Zitat Lin JM, Kilman VL, Keegan K, Paddock B, Emery-Le M, Rosbash M, Allada R (2002) A role for casein kinase 2alpha in the Drosophila circadian clock. Nature 420:816–820CrossRefPubMed Lin JM, Kilman VL, Keegan K, Paddock B, Emery-Le M, Rosbash M, Allada R (2002) A role for casein kinase 2alpha in the Drosophila circadian clock. Nature 420:816–820CrossRefPubMed
25.
Zurück zum Zitat Buchou T, Vernet M, Blond O, etal. (2003) Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23:908–915CrossRefPubMed Buchou T, Vernet M, Blond O, etal. (2003) Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23:908–915CrossRefPubMed
26.
Zurück zum Zitat Lowrey PL, Shimomura K, Antoch MP, etal. (2000) Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science 288:483–492CrossRefPubMed Lowrey PL, Shimomura K, Antoch MP, etal. (2000) Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science 288:483–492CrossRefPubMed
27.
Zurück zum Zitat Harms E, Young MW, Saez L (2003) CK1 and GSK3 in the Drosophila and mammalian circadian clock. Novartis Found Symp 253:267–277PubMed Harms E, Young MW, Saez L (2003) CK1 and GSK3 in the Drosophila and mammalian circadian clock. Novartis Found Symp 253:267–277PubMed
28.
Zurück zum Zitat Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM (2002) Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl Acad Sci USA 99:1182–1187PubMed Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM (2002) Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl Acad Sci USA 99:1182–1187PubMed
30.
Zurück zum Zitat Sathyanarayanan S, Zheng X, Xiao R, Sehgal A (2004) Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2A. Cell 116:603–615CrossRefPubMed Sathyanarayanan S, Zheng X, Xiao R, Sehgal A (2004) Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2A. Cell 116:603–615CrossRefPubMed
31.
Zurück zum Zitat Yang Y, He Q, Cheng P, Wrage P, Yarden O, Liu Y (2004) Distinct roles for PP1 and PP2A in the Neurospora circadian clock. Genes Dev 18:255–260PubMed Yang Y, He Q, Cheng P, Wrage P, Yarden O, Liu Y (2004) Distinct roles for PP1 and PP2A in the Neurospora circadian clock. Genes Dev 18:255–260PubMed
32.
Zurück zum Zitat Yeh E, Cunningham M, Arnold H, etal. (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308–318CrossRefPubMed Yeh E, Cunningham M, Arnold H, etal. (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308–318CrossRefPubMed
33.
Zurück zum Zitat ildesheim J, Belova GI, Tyner SD, Zhou X, Vardanian L, Fornace AJ Jr (2004) Gadd45 regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene 23:1829–1837CrossRefPubMed ildesheim J, Belova GI, Tyner SD, Zhou X, Vardanian L, Fornace AJ Jr (2004) Gadd45 regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene 23:1829–1837CrossRefPubMed
Metadaten
Titel
Tumor Suppression by the Mammalian Period Genes
verfasst von
Cheng Chi Lee
Publikationsdatum
01.05.2006
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 4/2006
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-9003-8

Weitere Artikel der Ausgabe 4/2006

Cancer Causes & Control 4/2006 Zur Ausgabe

Special Section on Cancer and Rhythm

Cancer and Rhythm

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.